The goal of Insilicomed is to provide integrated biocomputational engineering analysis solutions to medical technology companies to speed the product development cycle and reduce development costs.

Through computational models, Insilicomed's software and databases integrate biological science, medical knowledge and engineering principles. Insilicomed provides innovative predictive simulation tools and the detailed biological properties in a form suitable for engineers to perform quantitative analyses for rapidly testing new medical technology concepts and designs. Insilicomed's current platform technology models the physical properties of human cardiovascular tissue, including heart muscle and blood vessels. Existing modules of the software are designed for use by biomedical device manufacturers during the development phase of a new or improved cardiovascular product. Future modules will expand the use of this platform technology to medical imaging, surgical planning and other fields that would benefit from computational modeling tools of biological tissues and systems.